1. Home
  2. GDHG vs OGEN Comparison

GDHG vs OGEN Comparison

Compare GDHG & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDHG
  • OGEN
  • Stock Information
  • Founded
  • GDHG 2008
  • OGEN 1996
  • Country
  • GDHG China
  • OGEN United States
  • Employees
  • GDHG 650
  • OGEN N/A
  • Industry
  • GDHG Services-Misc. Amusement & Recreation
  • OGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDHG Consumer Discretionary
  • OGEN Health Care
  • Exchange
  • GDHG Nasdaq
  • OGEN Nasdaq
  • Market Cap
  • GDHG 9.5M
  • OGEN 9.8M
  • IPO Year
  • GDHG 2023
  • OGEN N/A
  • Fundamental
  • Price
  • GDHG $0.18
  • OGEN $1.13
  • Analyst Decision
  • GDHG
  • OGEN
  • Analyst Count
  • GDHG 0
  • OGEN 0
  • Target Price
  • GDHG N/A
  • OGEN N/A
  • AVG Volume (30 Days)
  • GDHG 7.2M
  • OGEN 133.4K
  • Earning Date
  • GDHG 08-01-2024
  • OGEN 08-12-2024
  • Dividend Yield
  • GDHG N/A
  • OGEN N/A
  • EPS Growth
  • GDHG N/A
  • OGEN N/A
  • EPS
  • GDHG 0.13
  • OGEN N/A
  • Revenue
  • GDHG $31,786,802.00
  • OGEN $20,629.00
  • Revenue This Year
  • GDHG N/A
  • OGEN N/A
  • Revenue Next Year
  • GDHG N/A
  • OGEN N/A
  • P/E Ratio
  • GDHG $1.39
  • OGEN N/A
  • Revenue Growth
  • GDHG N/A
  • OGEN N/A
  • 52 Week Low
  • GDHG $0.15
  • OGEN $0.97
  • 52 Week High
  • GDHG $24.99
  • OGEN $7.74
  • Technical
  • Relative Strength Index (RSI)
  • GDHG 46.70
  • OGEN 40.50
  • Support Level
  • GDHG $0.17
  • OGEN $1.00
  • Resistance Level
  • GDHG $0.20
  • OGEN $1.19
  • Average True Range (ATR)
  • GDHG 0.02
  • OGEN 0.06
  • MACD
  • GDHG 0.00
  • OGEN 0.03
  • Stochastic Oscillator
  • GDHG 51.94
  • OGEN 57.41

About GDHG Golden Heaven Group Holdings Ltd.

Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.

About OGEN Oragenics Inc.

Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.

Share on Social Networks: